focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGb Group Regulatory News (GBG)

Share Price Information for Gb Group (GBG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 344.20
Bid: 344.00
Ask: 345.20
Change: -0.80 (-0.23%)
Spread: 1.20 (0.349%)
Open: 350.00
High: 353.40
Low: 344.20
Prev. Close: 345.00
GBG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - GB Group plc

21 Sep 2022 10:08

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

Swedbank Robur Fonder AB

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

GB Group plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

20/09/2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

2 9/13p ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

7 449 174

 

2.95

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

7 449 174

2.95

 

 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

2.5p ordinary

Sale

29 132

GBp 610.2069

2.5p ordinary

Sale

126 392

GBp 611.0684

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

none

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

none

 

 

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

21/09/2022

Contact name:

Mats Frankeus

Telephone number*:

+46 8 58592400

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220921005553/en/

Copyright Business Wire 2022

Date   Source Headline
30th Jul 202111:30 amRNSDirector/PDMR Shareholding
30th Jul 202110:15 amRNSTotal Voting Rights
29th Jul 20213:55 pmRNSResult of AGM
29th Jul 20217:00 amRNSAGM Statement
19th Jul 20214:15 pmRNSBlock listing Interim Review
7th Jul 20215:33 pmRNSPosting of Annual Report and Notice of AGM
6th Jul 20214:00 pmRNSNotification of PDMR Interests
1st Jul 20217:00 amRNSDirectorate Change
30th Jun 20214:29 pmRNSTotal Voting Rights
29th Jun 20213:57 pmRNSNotification of PDMR Interests
21st Jun 20215:48 pmRNSNotification of Directors' Interests
16th Jun 20211:13 pmRNSNotification of Directors’ Interests
15th Jun 20217:00 amRNSFinal Results
28th May 20214:00 pmRNSTotal Voting Rights
17th May 20217:00 amRNSNotification of PDMR Shareholdings
30th Apr 202110:00 amRNSTotal Voting Rights
22nd Apr 20217:00 amRNSPre-Close Trading Statement
1st Apr 20217:00 amRNSSale of Employ and Comply business
31st Mar 20219:48 amRNSTotal Voting Rights
22nd Mar 202112:06 pmRNSHolding(s) in Company
26th Feb 20213:41 pmRNSTotal Voting Rights
25th Feb 20217:00 amRNSTrading Update
29th Jan 20212:45 pmRNSTotal Voting Rights
29th Jan 20212:28 pmRNSNotification of Directors’ Interests
28th Jan 20217:00 amRNSSuccession Plan for CFO
27th Jan 20213:58 pmRNSHolding(s) in Company
19th Jan 20217:00 amRNSBlock listing Interim Review
14th Jan 20217:00 amRNSSale of GBG Marketing Services
31st Dec 20207:00 amRNSTotal Voting Rights
18th Dec 20204:46 pmRNSNotification of PDMR Interests
17th Dec 20203:59 pmRNSHolding(s) in Company
16th Dec 20207:00 amRNSNotification of PDMR Interests
14th Dec 20207:00 amRNSAcquisition of HooYu Investigate
11th Dec 20205:03 pmRNSHolding(s) in Company
8th Dec 20207:00 amRNSHalf-year Report
30th Nov 20209:37 amRNSTotal Voting Rights
30th Oct 202011:00 amRNSTotal Voting Rights
22nd Oct 20203:21 pmRNSNotification of PDMR Interests
22nd Oct 20207:00 amRNSPre-Close Trading Statement and Notice of Results
1st Oct 20203:35 pmRNSNotification of Directors’ Interests
30th Sep 20209:05 amRNSTotal Voting Rights
1st Sep 20207:00 amRNSTotal Voting Rights
20th Aug 20207:00 amRNSInvestment in CredoLab Pte Ltd
19th Aug 20204:14 pmRNSDirectorate Change
10th Aug 202011:50 amRNSResult of AGM
10th Aug 20207:00 amRNSAGM Statement
5th Aug 20202:59 pmRNSHolding(s) in Company
31st Jul 20203:19 pmRNSTotal Voting Rights
22nd Jul 202010:26 amRNSPosting of Annual Report and Notice of AGM
20th Jul 20207:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.